new fda regulations for semaglutide Approves Oral Weight Loss FDA says 'no clinical need'

At Centra Internal Medicine, we understand that beginning a medical weight loss journey comes with many questions regarding expectations and timelines

2 Likes Davin8r April 14, 2025, 1:21am #73 Mind sharing what the X post was about for those of us without an account

Padhye-Pendse A, et al

For most patients, this translates to stronger appetite suppression and more significant weight reduction over time

These findings indicate that liraglutide, semaglutide, and tirzepatide were each associated with significant improvements in liver enzyme levels over the 36-week treatment period, without evidence of differential effects between agents (Table 6 and Figure 4)